Geoffrey Gates Scott

Director Geoffrey Gates Scott sold 20,000 AEHR shares at $82.13; stock now down 35.4% from 52-week high amid unprofitable operations.

Geoffrey Gates Scott, a director of AEHR TEST SYSTEMS, sold 20,000 shares (40.0% of his pre-transaction holdings) at $82.13 on 2026-07-16 for $1,642,650.00, leaving him with 30,000 shares. The sale occurred when the stock was already 35.4% below its 52-week high of $126.62 and has since fallen an additional 27.4% over 30 days. AEHR is unprofitable (net income of $-3,203,000.00 in the latest quarter) with negative annual revenue growth of -11.0% and a $2.6B market cap, creating a mismatch between valuation and fundamentals. At the same ticker, prior timing outcomes were mixed: 2 of 3 measurable 90-day outcomes showed negative returns (well-timed), though the April 2026 sales preceded a 43%+ rally over 30 days, suggesting the director has not consistently captured turning points at AEHR.

Director Scott Geoffrey Gates sells 60,000 AEHR shares for $5,660,000 on 2026-04-21, reducing stake by 54.5% to 50,000 shares

Scott Geoffrey Gates, a Director, executed 2 separate sales totaling 60,000 shares for $5,660,000 on 2026-04-21 at blended average price of $94.33, reducing his holdings from 110,000 shares to 50,000 shares—a 54.5% reduction. This sale comes at the stock's 52-week high of $93.72, following exceptional recent momentum (+171.5% over 30 days, +221.0% over 90 days), and occurs just 12 days after Gates executed 3 prior sales at the same ticker on 2026-04-09. The company's fundamentals are weak: revenue of $10,313,000 in the latest quarter with net income of $-3,203,000, annual revenue decline of -11.0%, and company-wide unprofitability in the most recent full fiscal year, against a $2.9B market cap. The concentrated liquidation of a significant portion of holdings at a multiyear high during a period of extreme volatility and deteriorating financial results warrants investor attention to whether the stock's recent surge is sustainable given underlying business challenges.

Director Scott Geoffrey Gates sells 35,000 shares (25% of holdings) for $2,373,250 at blended avg $67.81 as AEHR stock near 52-week peak

Scott Geoffrey Gates, a director at AEHR Test Systems, executed 3 separate sales totaling 35,000 shares for $2,373,250 on April 9, 2026, reducing his post-transaction holdings to 105,000 shares from 140,000 shares. The sales occurred at a blended average price of $67.81, occurring when the current stock price of $70.43 is at the 52-week high and has surged 65.9% over the prior 30 days and 167.6% over the prior 90 days. Against this backdrop of strong recent price momentum, the director divested a material 25% of his holdings. This sale of a significant block at elevated valuation levels, combined with the company's underlying operational strain—negative net income of $-3,203,000 in the latest quarter, negative full-year net income, and annual revenue decline of -11.0%—represents a divergence between near-term price strength and deteriorating fundamental performance that warrants investor attention.